Clinical studies have revealed mutations (3–5) or the downregulation (5) of RBFOX1 in the specimens obtained from patients with epilepsy or MCD; specifically, the specimens were not from the actual epileptogenic lesions. This evidence concerns the gene RBFOX1 and epilepsy.